| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242083 | Respiratory Medicine | 2011 | 8 Pages |
Abstract
Bronchial NO flux appears to be sensitive to oral dexamethasone and may provide a useful exploratory endpoint for the analysis of novel anti-inflammatory therapies in smokers with asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Mark Spears, Christopher J. Weir, Andrew D. Smith, Charles McSharry, Rekha Chaudhuri, Martin Johnson, Euan Cameron, Neil C. Thomson,